Eosinophilic asthma is a severe form of asthma caused by excess amounts of white blood cells that cause inflammation in the respiratory system. It’s rare and difficult to treat, and requires ...

eosinophils, neutrophils, mast cells and basophils to promote inflammation and exacerbation of asthma.

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...

Only two cases of chronic hiccups tied to eosinophilic esophagitis have previously been reported, the man's doctors say.

Survey results show that clinicians largely disagree about choices for severe asthma treatment, due primarily to a lack of ...

The prospective, epidemiologic School Inner-City Asthma Study (SICAS) evaluated potential biomarkers of inflammation associated with radon exposure among children aged 4 to 13 years with persistent ...

The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.

AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma treatment Fasenra.

Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used ...

Nucala (mepolizumab) is indicated for the treatment of severe asthma and other conditions related to high levels of eosinophils (a type of white blood cell). Nucala is a biologic and belongs to a ...